These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29510290)

  • 21. Quantifying eloquent locations for glioblastoma surgery using resection probability maps.
    Müller DMJ; Robe PA; Ardon H; Barkhof F; Bello L; Berger MS; Bouwknegt W; Van den Brink WA; Conti Nibali M; Eijgelaar RS; Furtner J; Han SJ; Hervey-Jumper SL; Idema AJS; Kiesel B; Kloet A; De Munck JC; Rossi M; Sciortino T; Vandertop WP; Visser M; Wagemakers M; Widhalm G; Witte MG; Zwinderman AH; De Witt Hamer PC
    J Neurosurg; 2021 Mar; 134(3):1091-1101. PubMed ID: 32244208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of treatment on survival of patients with secondary glioblastoma.
    Hamisch C; Ruge M; Kellermann S; Kohl AC; Duval I; Goldbrunner R; Grau SJ
    J Neurooncol; 2017 Jun; 133(2):309-313. PubMed ID: 28560660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Counseling Patients with a Glioblastoma Amenable Only for Subtotal Resection: Results of a Multicenter Retrospective Assessment of Survival and Neurologic Outcome.
    Coburger J; Segovia J; Ganslandt O; Ringel F; Wirtz CR; Renovanz M
    World Neurosurg; 2018 Jun; 114():e1180-e1185. PubMed ID: 29621607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    Coburger J; Hagel V; Wirtz CR; König R
    PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the cutting edge of glioblastoma surgery: where neurosurgeons agree and disagree on surgical decisions.
    Müller DMJ; Robe PA; Ardon H; Barkhof F; Bello L; Berger MS; Bouwknegt W; Van den Brink WA; Conti Nibali M; Eijgelaar RS; Furtner J; Han SJ; Hervey-Jumper SL; Idema AJS; Kiesel B; Kloet A; Mandonnet E; De Munck JC; Rossi M; Sciortino T; Vandertop WP; Visser M; Wagemakers M; Widhalm G; Witte MG; Zwinderman AH; De Witt Hamer PC
    J Neurosurg; 2022 Jan; 136(1):45-55. PubMed ID: 34243150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
    Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS
    Int J Radiat Oncol Biol Phys; 1993 May; 26(2):239-44. PubMed ID: 8387988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
    World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of glioblastoma in the elderly: the impact of complications.
    Karsy M; Yoon N; Boettcher L; Jensen R; Shah L; MacDonald J; Menacho ST
    J Neurooncol; 2018 May; 138(1):123-132. PubMed ID: 29392589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.
    Wisoff JH; Boyett JM; Berger MS; Brant C; Li H; Yates AJ; McGuire-Cullen P; Turski PA; Sutton LN; Allen JC; Packer RJ; Finlay JL
    J Neurosurg; 1998 Jul; 89(1):52-9. PubMed ID: 9647172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme.
    McGirt MJ; Mukherjee D; Chaichana KL; Than KD; Weingart JD; Quinones-Hinojosa A
    Neurosurgery; 2009 Sep; 65(3):463-9; discussion 469-70. PubMed ID: 19687690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontal operculum gliomas: language outcome following resection.
    Rolston JD; Englot DJ; Benet A; Li J; Cha S; Berger MS
    J Neurosurg; 2015 Apr; 122(4):725-34. PubMed ID: 25635477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of surgical decision making and resulting outcome in patients with highly eloquent glioblastoma: Results of a multicenter assessment.
    Coburger J; Renovanz M; Ganslandt O; Ringel F; Wirtz CR; von Riehm JS
    Clin Neurol Neurosurg; 2017 Nov; 162():29-35. PubMed ID: 28915414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
    Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
    World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.
    Marko NF; Weil RJ; Schroeder JL; Lang FF; Suki D; Sawaya RE
    J Clin Oncol; 2014 Mar; 32(8):774-82. PubMed ID: 24516010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
    Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
    World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma.
    Meier R; Porz N; Knecht U; Loosli T; Schucht P; Beck J; Slotboom J; Wiest R; Reyes M
    J Neurosurg; 2017 Oct; 127(4):798-806. PubMed ID: 28059651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-field intraoperative MRI in glioma surgery: A prospective study with volumetric analysis of extent of resection and functional outcome.
    Leroy HA; Delmaire C; Le Rhun E; Drumez E; Lejeune JP; Reyns N
    Neurochirurgie; 2018 Jun; 64(3):155-160. PubMed ID: 29754739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
    Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
    J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.